Vaccine antibodies and T- and B-cell interaction in juvenile systemic lupus erythematosus

Lupus

Volumn 20, Issue 7, 2011, Pages 736-744

  Miyamoto, M ^a   Ono, E ^a   Barbosa, Cpl ^a   Terreri, Mtra ^a   Hilário, Moe ^a   Salomao R ^a   Moraes Pinto, Mi De ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

apoptosis; lymphocyte activation; measles antibodies; systemic lupus erythematosus; tetanus antibodies

Indexed keywords

AZATHIOPRINE; CASPASE 3; CD38 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEASLES ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TETANUS ANTIBODY;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL INTERACTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS; LYMPHOCYTE ACTIVATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTIGENS; ANTIGENS, VIRAL; APOPTOSIS; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEASLES VACCINE; TETANUS TOXOID;

EID: 79957587347     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310397409     Document Type: Article

References (35)

1. Munoz LE, Gaipl US, Franz S, et al. SLE-a disease of clearance deficiency?. Rheumatology. 2005 ; 44: 1101-1107
2. Spronk PE, Van Der Gun BT, Limburg PC, Kallenberg CG. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation. Clin Exp Immunol. 1993 ; 93: 39-44 (Pubitemid 23195937)
3. Spronk PE, Horst G, Van Der Gun BT, Limburg PC, Kallenberg CG. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE). Clin Exp Immunol. 1996 ; 104: 446-453 (Pubitemid 26000372)
4. Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol. 2001 ; 2: 764-766
5. Bijl M, Horst G, Limburg PC, Kallenberg CGM. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis. 2001 ; 60: 523-526 (Pubitemid 32417429)
6. Nagafuchi H, Shimoyama Y, Kashiwakura J, Takeno M, Sakane T, Suzuki N. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2003 ; 21: 71-77 (Pubitemid 36267534)
7. Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol. 2006 ; 239: 121-128 (Pubitemid 44037544)
8. Liphaus BL, Kiss MHB, Carrasco S, Goldenstein-Schainberg C. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus. J Rheumatol. 2007 ; 34: 1580-1584 (Pubitemid 47067999)
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
10. Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 1999 ; 42: 1354-1360 (Pubitemid 30265592)
11. American Academy of Pediatrics. Active immunization. In: Pickering LK (ed.), 2006 Red Book: Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2006. p. 23-27.
12. Harari A, Rizzardi GP, Ellefsen K, et al. Analysis of HIV-1 and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood. 2002 ; 100: 1381-1387 (Pubitemid 34864295)
13. Geginat J, Lanzavecchia A, Sallusto F. Proliferation and differentiation potential of human CD8+ memory T cell subsets in response to antigen or homeostatic cytokines. Blood. 2003 ; 101: 4260-4266 (Pubitemid 36857786)
14. Kristiansen M, Aggerbeck H, Heron I. Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. Acta Pathol Microbiol Scand. 1997 ; 105: 843-853 (Pubitemid 27483631)
15. De Moraes-Pinto MI, Almeida AC, Kenj G, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis. 1996 ; 173: 1077-1084 (Pubitemid 26251448)
16. Borrow R, Balmer P, Roper MH. The immunological basis for immunization series. Module 3: Tetanus Update 2006. World Health Organization 2007: 1-52.
17. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: Reevaluation of protective titers. J Infect Dis. 1990 ; 162: 1036-1042 (Pubitemid 20353580)
18. Ferreira S, Vasconcelos J, Marinho A, et al. CD4 lymphocytopenia in systemic lupus erythematosus. Acta Reumatol Port. 2009 ; 34: 200-206
19. Pavón EJ, Muñoz P, Navarro MD, et al. Increased association of CD38 with lipid rafts in T cells from patients with systemic lupus erythematosus and in activated normal T cells. Mol Immunol. 2006 ; 43: 1029-1039 (Pubitemid 41814420)
20. Miyamoto M, Pessoa SD, Ono E, et al. Low CD4+ T-cell levels and B-Cell apoptosis in vertically HIV-exposed noninfected children and adolescents. J Trop Pediatr. 2010 ; 56: 427-432
21. Wong CK, Lit LC, Tam LS, Li EK, Lam CW. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology. 2005 ; 44: 989-994 (Pubitemid 41487170)
22. Henneken M, Dörner T, Burmester GR, Berek C. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther. 2005 ; 7: R1001 - R1013
23. Holvast A, Huckriede A, Wilschut J, et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis. 2006 ; 65: 913-918
24. Abu-Shakra M, Press J, Buskila D, Sukenik S. Influenza vaccination of patients with systemic lupus erythematosus: Safety and immunogenicity issues. Autoimmunity Rev. 2007 ; 6: 543-546 (Pubitemid 47374614)
25. Holvast A, van Assen S, de Haan A, et al. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Rheumatology. 2009 ; 48: 1294-1299
26. Battafarano DF, Battafarano NJ, Larsen L, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum. 1998 ; 41: 1828-1834 (Pubitemid 28465537)
27. Pesce MA. Reference ranges for laboratory tests and procedures. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, Nelson Textbook of Pediatrics, 18th edn. Saunders Elsevier; 2007. p. 2943-2949.
28. Zaccarelli-Filho CA, Ono E, Machado DM, et al. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Cytometry B Clin Cytom. 2007 ; 72: 14-21 (Pubitemid 46105453)
29. Lima M, De Menezes Succi RC, Nunes Dos Santos AM, Weckx Ly, De Moraes-Pinto MI. Rubella immunization in human immunodeficiency virus type 1-infected children: cause for concern in vaccination strategies. Pediatr Infect Dis J. 2004 ; 23: 604-607 (Pubitemid 38924882)
30. Gouvêa AFTB, De Moraes-Pinto MI, Ono E, et al. Immunogenicity and tolerability of Hepatitis A vaccine in HIV-infected children. Clin Infect Dis. 2005 ; 41: 544-548 (Pubitemid 41099652)
31. Jiang Y, Shang H, Zhang Z, et al. Alterations of natural killer cell and T-lymphocyte counts in adults infected with human immunodeficiency virus through blood and plasma sold in the past in China and in whom infection has progressed slowly over a long period. Clin Diagn Lab Immunol. 2005 ; 12: 1275-1279 (Pubitemid 41626595)
32. Deuffic-Burban S, Losina E, Wang B, et al. Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling. Eur J Epidemiol. 2007 ; 22: 737-744 (Pubitemid 47476685)
33. Erkeller-Yüsel F, Hulstaart F, Hannet I, Isenberg D, Lydyard P. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus. 1993 ; 2: 227-231 (Pubitemid 23295636)
34. Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Clin Exp Immunol. 2005 ; 141: 165-173 (Pubitemid 40904654)
35. Yabuhara A, Yang FC, Nakazawa T, et al. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J Rheumatol. 1996 ; 23: 171-177 (Pubitemid 26037216)